|
The decision to locate Takeda's new worldwide centre for Active Pharmaceutical Ingredient (API) manufacturing, development and technical support in Ireland represents a key strategic addition to the group's global production network. Located at the high technology Pharmaceutical and Biotechnology Business Park at Grange Castle in Clondalkin Dublin Takeda Ireland Ltd. (Grange Castle) is Takeda's first API plant constructed outside Japan. TPI will be the launch vehicle for new strategic products for global markets developing and producing API's from clinical trial stages through to launch and full commercialisation. In our new multipurpose plant we plan to develop for clinical trial supply numerous new products each year, while also supplying world markets with existing blockbuster products such as pioglitazone (brand name: Actos). We rely on our world-class staff, equipment and systems to meet the challenge of competing in our leading edge markets. Our role includes responsibility for technology transfer and technical support of contract manufacturers, which supplement our global supply requirements.
|
Registered in Ireland No. 233508
Registered Office: Bray Business Park, Kilruddery, Co, Wicklow